Gold Standard Phantoms are pleased to announce that our ongoing efforts to bring ASL quantitative measuring to the forefront of the MRI industry has been remarked upon in EIBIR’s latest strategic research agenda for biomedical imaging. (Link to Website)
In addition, our very own Xavier Golay is a contributing author, which highlights a landmark time for Gold Standard Phantoms’ position in the field of MRI.
The European Institute for Biomedical Imaging Research (EIBIR) is a non-profit limited liability company that was founded in 2006 by the European Society of Radiology (ESR), dedicated to the coordination and development of biomedical imaging research in Europe.
EIBIR aims to coordinate and support the development of biomedical imaging technologies and we are happy to collaborate with them for the dissemination of knowledge with the ultimate goal of improving the diagnosis, treatment and prevention of disease.
The platform supports research networking activities and plays a key role in spreading good practice, promoting common initiatives and interoperability in the field of biomedical imaging research.
At Gold Standard Phantoms we are striving to introduce new developments and innovations in MRI to promote the clinical availability of quantitative imaging through the use non-invasive biomarkers to better monitor disease characteristics as well as help with early detection of disease to facilitate preventative measures, ultimately leading to improved patient outcomes.
